Bass, Berry & Sims was recognized as a winner in the Healthcare/Life Sciences Deal of the Year ($50MM to $100MM) category at the 23rd Annual M&A Advisor Awards. These annual awards honor the year’s leading M&A transactions, companies and dealmakers.
The firm was honored in that category related to its work representing TT Capital Partners in the recapitalization of Pyx Health. This deal was also named a finalist in the Private Equity Deal of the Year ($75MM to $100MM) category. We represented TT Capital Partners – a value-add healthcare investor that provides capital, expertise and insight to healthcare technology and services companies. Pyx Health is a tech-enabled services company that provides health plans and their members an innovative, scalable solution that uniquely reduces loneliness and social isolation. The company’s innovative app-based technology, paired with timely human interventions, improves patient and member outcomes in vulnerable populations, reduces financial burdens on the healthcare system, and promotes health equity. Pyx Health’s collaboration with TT Capital Partners is expected to raise Pyx Health’s profile in its mission of tackling the loneliness epidemic, amplifying its reach and impact within the healthcare sector and beyond. This strategic alliance underscores Pyx Health’s commitment to innovation and community health, paving the way for future growth and development in addressing pressing societal challenges. More about the investment can be found here.
The M&A Advisor Awards were presented during the 2024 Future of Dealmaking Summit on November 19-20 in New York City. For a complete list of winners, click here. In September, M&A Advisor released its full list of finalists for the 2024 awards and Bass, Berry & Sims had four transactions recognized among nine different categories.
About our Healthcare, Mergers & Acquisitions and Private Equity Practices
Bass, Berry & Sims has a comprehensive M&A practice representing buyers and sellers in both public and private company strategic transactions, as well as financial sponsor transactions. Named 2021 Law Firm of the Year by The M&A Advisor, the firm has served as lead counsel in more than 400 transactions ranging in size from $20 million to more than $15 billion in the last four years. Our attorneys have represented healthcare clients in transactions with a combined value in excess of $136 billion. The firm’s Private Equity Team has served as counsel in hundreds of private equity-backed deals across many industries, most notably healthcare, but also including financial services, food and beverage, manufacturing, media, technology, consumer products and retail. As a reflection of this body of work, our firm is regularly ranked in the top 25 and top 10 by industry leading league tables across a variety of categories, including most recently #9 most active in healthcare private equity and #20 most active in U.S. private equity representing investors (PitchBook Q3 2024). More information about these practices can be found here.
The M&A Advisor
Now in its 26th year, The M&A Advisor was founded to offer insights and intelligence on mergers and acquisitions, establishing the industry’s leading media outlet in 1998. Today, the firm is recognized as the world’s premier leadership organization for mergers & acquisition, restructuring and corporate finance professionals, delivering a range of integrated services, including the most active online community of M&A professionals called M&A Connects. www.maadvisor.com.